Guiding Dose Increases in Patients Incompletely Responsive to Usual Doses of Atomoxetine
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to test the value of dose increases in patients with residual
ADHD symptoms after treatment with the usual target dose of atomoxetine